DTIL 4.72 (+2.61%)
US74019P1084BiotechnologyBiotechnology

Precision BioSciences (DTIL) Stock Highlights

4.72 | +2.61%
2024-12-21 07:07:57
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The companys segments include Therapeutics and Food out of which the Therapeutics segment act as a key revenue driver for the firm.

Statistics

Range Today
4.51 5.01
Volume Today 705.3K
Range 1 Year
4.13 19.43
Volume 1 Year 20.08M
Range 3 Year
4.13 258.6
Volume 3 Year 38.09M
Range 10 Year
4.13 710.1
Volume 10 Year 52.35M

Highlights

Market Capitalization 64.28M (small)
Floating Shares 6.2M
Current Price 4.72
Price To Earnings 20.87
Price To Revenue -0.09
Price To Book 0.97
Earnings Per Share 0.4
Payout Ratio 0%

Performance

Latest +2.61%
1 Month -35.43%
3 Months -50.47%
6 Months -53.27%
1 Year -57.36%
3 Years -98.1%
5 Years -98.7%
10 Years -99.13%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.